The potential role of somatostatin analogues in breast cancer treatment.

por Pollak, M.
Publicado 1997

Electron-electron interactions in disordered systems

por Efros, AL, Pollak, M
Publicado 1985

Hopping transport in solids

por Pollak, M, Shklovskii, B
Publicado 1991

Co-targeting IGF-1R and c-kit: synergistic inhibition of proliferation and induction of apoptosis in H 209 small cell lung cancer cells

por Camirand, A, Pollak, M
Publicado 2004

Reply: ‘Pre-treatment levels of circulating free IGF-1 identify NSCLC patients who derive clinical benefit from figitumumab’

por Gualberto, A, Hixon, M L, Pollak, M
Publicado 2011

Reduced mammary gland carcinogenesis in transgenic mice expressing a growth hormone antagonist

por Pollak, M, Blouin, M-J, Zhang, J-C, Kopchick, J J
Publicado 2001

Insulin-like growth factors and risk of kidney cancer in men

por Major, J M, Pollak, M N, Snyder, K, Virtamo, J, Albanes, D
Publicado 2010

Insulin-like growth factors and liver cancer risk in male smokers

por Major, J M, Stolzenberg-Solomon, R Z, Pollak, M N, Snyder, K, Virtamo, J, Albanes, D
Publicado 2010

Magnesium intake, plasma C-peptide, and colorectal cancer incidence in US women: a 28-year follow-up study

por Zhang, X, Giovannucci, E L, Wu, K, Smith-Warner, S A, Fuchs, C S, Pollak, M, Willett, W C, Ma, J
Publicado 2012

Pre-treatment levels of circulating free IGF-1 identify NSCLC patients who derive clinical benefit from figitumumab

por Gualberto, A, Hixon, M L, Karp, D D, Li, D, Green, S, Dolled-Filhart, M, Paz-Ares, L G, Novello, S, Blakely, J, Langer, C J, Pollak, M N
Publicado 2011

Pre-treatment levels of circulating free IGF-1 identify NSCLC patients who derive clinical benefit from figitumumab

por Gualberto, A, Hixon, M L, Karp, D D, Li, D, Green, S, Dolled-Filhart, M, Paz-Ares, L G, Novello, S, Blakely, J, Langer, C J, Pollak, M N
Publicado 2012

Circulating insulin-like growth factor axis and the risk of pancreatic cancer in four prospective cohorts

por Wolpin, B M, Michaud, D S, Giovannucci, E L, Schernhammer, E S, Stampfer, M J, Manson, J E, Cochrane, B B, Rohan, T E, Ma, J, Pollak, M N, Fuchs, C S
Publicado 2007

GH safety workshop position paper: a critical appraisal of recombinant human GH therapy in children and adults

por Allen, D B, Backeljauw, P, Bidlingmaier, M, Biller, B M K, Boguszewski, M, Burman, P, Butler, G, Chihara, K, Christiansen, J, Cianfarani, S, Clayton, P, Clemmons, D, Cohen, P, Darendeliler, F, Deal, C, Dunger, D, Erfurth, E M, Fuqua, J S, Grimberg, A, Haymond, M, Higham, C, Ho, K, Hoffman, A R, Hokken-Koelega, A, Johannsson, G, Juul, A, Kopchick, J, Lee, P, Pollak, M, Radovick, S, Robison, L, Rosenfeld, R, Ross, R J, Savendahl, L, Saenger, P, Toft Sorensen, H, Stochholm, K, Strasburger, C, Swerdlow, A, Thorner, M
Publicado 2015